Need Help?

Personalised therapy with MEK inhibition leads to a sustained complete response in an adolescent patient with a recurrent malignant peripheral nerve sheath tumor

Whole genome sequencing of tumour (90X) - normal (30X) patient pair and bulk transcriptome sequencing (80M PE reads) of tumour sample.

Request Access

Zero Childhood Cancer Data Access Policy

Please see URL for full policy

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001004899 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF00005214253 fastq.gz 39.2 GB Report
EGAF00005214254 fastq.gz 44.5 GB Report
EGAF00005214255 fastq.gz 39.6 GB Report
EGAF00005214256 fastq.gz 45.4 GB Report
EGAF00005214257 fastq.gz 41.6 GB Report
EGAF00005214258 fastq.gz 48.3 GB Report
EGAF00005214259 fastq.gz 40.0 GB Report
EGAF00005214260 fastq.gz 45.7 GB Report
EGAF00005214261 fastq.gz 8.6 GB Report
EGAF00005214262 fastq.gz 8.7 GB Report
10 Files (361.5 GB)